Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dickerson

Showing results (271-280 of 300) with videos related to

Pageof 30
Sort By:
Water Research|May 4, 2007
Exposing water samples to ultraviolet light improves fluorometry for detecting human fecal contaminationPeter G Hartel, Charles Hagedorn, Jennifer L McDonald, et al.
Molecular Pharmacology|August 18, 2023
Development of a Selective and High Affinity Radioligand, [<sup>3</sup>H]VU6013720, for the M<sub>4</sub> Muscarinic ReceptorAidong Qi, Haley E Kling, Natasha Billard, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Discovery and optimization of a novel CNS penetrant series of mGlu<sub>4</sub> PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian modelCaitlin N Kent, Mark G Fulton, Kaylee J Stillwell, et al.
Neuron|December 22, 2017
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M<sub>4</sub> Muscarinic ReceptorMark S Moehle, Tristano Pancani, Nellie Byun, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse EventsJulie L Engers, Elizabeth S Childress, Madeline F Long, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 28, 2018
M<sub>1</sub>-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionSean P Moran, Jonathan W Dickerson, Hyekyung P Cho, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory ReconsolidationAdam G Walker, Douglas J Sheffler, Andrew S Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
Annals of Internal Medicine|August 15, 1993
Babesiosis in Washington State: a new species of Babesia?R E Quick, B L Herwaldt, J W Thomford, et al.
ACS Chemical Neuroscience|August 8, 2018
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M<sub>1</sub> Positive Allosteric ModulatorsJulie L Engers, Aaron M Bender, Jacob J Kalbfleisch, et al.
Pageof 30

Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
Water Research|May 4, 2007
Exposing water samples to ultraviolet light improves fluorometry for detecting human fecal contaminationPeter G Hartel, Charles Hagedorn, Jennifer L McDonald, et al.
Molecular Pharmacology|August 18, 2023
Development of a Selective and High Affinity Radioligand, [<sup>3</sup>H]VU6013720, for the M<sub>4</sub> Muscarinic ReceptorAidong Qi, Haley E Kling, Natasha Billard, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Discovery and optimization of a novel CNS penetrant series of mGlu<sub>4</sub> PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian modelCaitlin N Kent, Mark G Fulton, Kaylee J Stillwell, et al.
Neuron|December 22, 2017
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M<sub>4</sub> Muscarinic ReceptorMark S Moehle, Tristano Pancani, Nellie Byun, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse EventsJulie L Engers, Elizabeth S Childress, Madeline F Long, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 28, 2018
M<sub>1</sub>-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionSean P Moran, Jonathan W Dickerson, Hyekyung P Cho, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory ReconsolidationAdam G Walker, Douglas J Sheffler, Andrew S Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
Annals of Internal Medicine|August 15, 1993
Babesiosis in Washington State: a new species of Babesia?R E Quick, B L Herwaldt, J W Thomford, et al.
ACS Chemical Neuroscience|August 8, 2018
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M<sub>1</sub> Positive Allosteric ModulatorsJulie L Engers, Aaron M Bender, Jacob J Kalbfleisch, et al.
Pageof 30